Craft

AsclepiX Therapeutics

Total Funding

$40 M

AsclepiX Therapeutics Summary

Company Summary

Overview
AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. It offers the treatment of retinal disease and cancer. The Company also develops its treatment for diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD).
Type
Private
Status
Active
Founded
2011
HQ
Baltimore, MD, US | view all locations
Website
http://asclepix.com/
Cybersecurity rating
Sectors

Key People

  • Robert J. Dempsey

    Robert J. Dempsey, Chief Executive Officer and President

    • Niranjan B. Pandey

      Niranjan B. Pandey, Vice President, Research and Development

    • Aleksander S. Popel

      Aleksander S. Popel, Founder, Chief Scientific Advisor

    • Kevin Slawin

      Kevin Slawin, Chief Executive Officer, Director

      LocationsView all

      2 locations detected

      • Baltimore, MD HQ

        United States

        301 W 29th St #2004

      • Jersey City, NJ

        United States

        185 Hudson St #2500

      Footer menu